Join us for "Let's Talk Legal - How to... Navigate the Legal Landscape: A workshop series for early stage ventures." This series of 3 independent workshops is designed to help entrepreneurs demystify the legal landscape and fill in the blanks. The series at JLABS @ Toronto is organized by the Johnson & Johnson law department, in partnership with Blakes, one of Canada's leading law firms.
This is the first workshop in the series of 3 - you do not need to attend the other workshops in order to register.
Workshop 1 | Preparing for your Future as an Entrepreneur: Legal Basics for Start-ups | Sept 29 read more»
Workshop 2 | Protecting your Intellectual Property | Oct 25
Workshop 3 | Venture Financing: What to Expect and Strategies for Success | Nov 29 read more»
The "How to..." workshop series is dedicated to giving you the keys to a successful business, from creation to exit. As with all our events, the "Let's Talk Legal - How to..." workshop is interactive and informal so bring your questions with you!
Let's Talk Legal Workshop 1 | Preparing For Your Future as an Entrepreneur: Legal Basics for Start-ups
"A journey of a thousand miles begins with one step!"- Lao Tzu
You've always been a successful scientist and now you want to become a successful entrepreneur! So planning your next step and having the appropriate information is key to protect your new venture and ensure a smoother path forward.
This event is the first in a series of presentations on key legal considerations and issues facing entrepreneurs. It is brought to you by Johnson & Johnson's law department working with one of Canada's leading law firms, Blakes. The lawyers presenting these workshops have extensive experience working with life sciences companies ranging from very early-stage ventures through to multi-national public companies.
This practical session will focus on organizing your venture with an eye to the future, key topics include:
- How to establish an appropriate foundation for your venture and anticipate future legal issues
- How to address common legal issues for early-stage companies
- How to work efficiently and cost-effectively with professional services providers such as law firms
Future workshops will focus on issues such as the protection of intellectual property, licensing arrangements and financing transactions. Sign up for workshop 1 now and look for the rest coming in the future.
11:00 AM | Registration Opens, Networking
11:30 AM | Presentation
12:15 PM | Q&A
12:30 PM | Lunch and Networking
1:30 PM | Program Close
Maurizio Romano | Director, Law, Janssen, Inc. read bio»
Christopher Jones | Partner, Blake, Cassels & Graydon LLP read bio»
Justin Drake | Senior Associate , Blake, Cassels & Graydon LLP read bio»
$40 | General Public
$30 | Student/Academic
$55 | At the door
Please note: fees do not go to the presenting lawyers, they cover only catering and event costs
JLABS @ Toronto
661 University Ave, Suite 1300
Maurizio Romano | Director, Law, Janssen Inc.
Maurizio Romano is currently the Director of Law for Janssen Inc., the Canadian pharmaceutical business of Johnson & Johnson. His primary responsibilities include supporting all matters for the immunology, oncology, and BioAdvance patient support businesses. He also provides global legal support to Johnson & Johnson Innovation, JLABS. Prior to joining Johnson & Johnson in 2013, Maurizio practiced for nine years as an M&A and Competition lawyer at Blake, Cassels & Graydon, LLP. Maurizio obtained his Juris Doctor from the University of Toronto; and a Bachelor of Education and a Bachelor of Arts from Queen's University.
Connect with Maurizio:
Christopher Jones | Partner, Blake, Cassels & Graydon LLP
Christopher's practice focuses on mergers and acquisitions and private equity, venture and corporate finance transactions. He regularly advises Canadian, U.S. and other international clients on a wide variety of public and private acquisition and business combination transactions, public offerings and private placements of equity and debt securities. His clientele include private equity, venture capital and pension funds and businesses that range from early-stage ventures to publicly-traded, multi-national corporations operating in a variety of industries, including biotechnology, pharmaceuticals, technology, manufacturing, mining and resources.
Christopher currently serves as a member of the Ontario Bar Association Securities Law Subcommittee and also serves on the World Securities Law Report advisory board.
Prior to joining Blakes, Christopher spent five years practicing law in the United States.
Connect with Christopher:
Justin Drake | Senior Associate , Blake, Cassels & Graydon LLP
Justin is a senior associate at Blakes and practices corporate and commercial law. He advises clients in connection with a variety of transactions, including acquisitions and divestitures, venture capital, strategic and private equity financings and joint ventures. He is experienced in advising both emerging companies and investors operating within the life sciences and technology sectors.
Connect with Justin:
When & Where
JLABS @ Toronto
JLABS, part of Johnson & Johnson Innovation, is a network of life science incubators providing emerging companies many of the advantages of being in a big company, without the capital investment. JLABS offers singular bench tops, modular wet lab units and office space on a short-term basis, allowing companies to pay only for the space they need, with an option to quickly expand when they have the resources to do so. Companies residing at JLABS also have access to core research labs hosting specialized capital equipment and shared administrative areas. JLABS is an open innovation model, and the agreement for space does not grant JLABS or Johnson & Johnson Innovation any stake or rights in the companies, nor will the companies have a guaranteed future affiliation with JLABS. The flagship facility is located in San Diego at Janssen's West Coast Research Center, and JLABS has now two established locations in San Francisco - one through a collaboration with the California Institute for Quantitative Biosciences (QB3) and a second standalone facility - one in Boston through a collaboration with Lab Central, one in Houston through a collaboration with TMC, and one in Toronto through a collaboration with MaRS. For more information please visit jlabs.jnjinnovation.com.